Opsy Holding

Opsy Holding Interest Coverage

The Interest Coverage Ratio of Opsy Holding (OPSYH.SL) as of Oct 29, 2026 is -17.08. In the previous year, Interest Coverage Ratio was -48.89 — a change of -65.07% (higher).

Interest Coverage

-17.08

YoY

-65.07%

Last updated:

Interest Coverage Ratio of Opsy Holding is 2024 -17.08 . Interest Coverage Ratio of Opsy Holding was 2023 -48.89 . It decreases by -65.07% higher compared to the previous year.

The Opsy Holding Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2014
-558.33 SEK
Jan 1, 2015
-666.85 SEK
Jan 1, 2016
-67,040.67 SEK
Jan 1, 2017
-39.68 SEK
Jan 1, 2020
-7,186.00 SEK
Jan 1, 2021
-35,766.00 SEK
Jan 1, 2023
-48.89 SEK
Jan 1, 2024
-17.08 SEK
The Opsy Holding Interest Coverage history
YEARInterest CoverageYoY
-17.08-65.07%
-48.89-99.86%
-35,766.00+397.72%
-7,186.00+18,007.73%
-39.68-99.94%
-67,040.67+9,953.38%
-666.85+19.44%
-558.33—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Opsy Holding Stock analysis

What does Opsy Holding do? Opsy Holding AB develops a software platform for insurance companies and medical advisors, focusing on anti-metastatic therapies related to the Wnt-5a protein. The company's products target the metastatic process through specific small molecules that interact with Wnt-5a mechanisms. Insurance companies and medical advisors purchase the platform to integrate advanced therapeutic insights into their services. The company's primary market segment consists of healthcare technology providers seeking innovative solutions for metastasis research. Opsy Holding AB's software platform is designed to support medical advisors and insurance firms in evaluating small molecules that specifically interact with the Wnt-5a protein's role in metastasis. The company's focus on Wnt-5a mechanisms positions its products for specialized healthcare applications. Insurance companies use the platform to enhance their risk assessment models with advanced therapeutic data. The company's business model centers on providing a technology platform that bridges medical research and insurance applications. By targeting the Wnt-5a protein's role in metastasis, Opsy Holding AB offers a niche solution for healthcare technology providers. The platform's value lies in its ability to connect specific small molecule evaluations with practical applications in insurance and medical advisory services. Opsy Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Opsy Holding stock

Interest Coverage Ratio of Opsy Holding is -17.08 in 2024.

Interest Coverage Ratio of Opsy Holding changed from -48.89 to -17.08, representing a -65.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Opsy Holding since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Opsy Holding with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Opsy Holding

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Opsy Holding